GC-101(Shanghai Jingshan Biotech)

N/A

Report date: 2025/03/03 14:54:02

Base Information

Drug NameGC-101(Shanghai Jingshan Biotech)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCOL7A1 gene transference
TargetsCollagen alpha-1(VII) chain
Therapy Area/IndicationsEpidermolysis Bullosa Dystrophica
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Jingshan Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Jingshan Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsEpidermolysis Bullosa Dystrophica
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A